Teriparatide vs Abaloparatide
The two anabolic bone-building agents — the established teriparatide vs the newer analog studied for denser bone, faster. Here's a neutral, sourced side-by-side — no hype, every claim links to its evidence.
Teriparatide
ApprovedAlso: Teriparatide plus zoledronic acid sequential treatment, Teriparatide followed by Zoledronic Acid (TOPaZ Trial Protocol)
Teriparatide is a man-made medicine that acts like a specific hormone your body makes to build bone. It is used by people with weak bones, a condition known as osteoporosis, to help make their bones stronger and prevent breaks.
Abaloparatide
ApprovedAlso: Abaloparatide Treatment Protocol, abaloparatide
Abaloparatide is a man-made medicine used to help bones get stronger. It is an injection given just under the skin, usually in the stomach area.
At a Glance
| Teriparatide | Abaloparatide | |
|---|---|---|
| Research status | Approved | Approved |
| Highest-tier evidence | Peer-reviewed study | Peer-reviewed study |
| Research citations | 1 | 12 |
| Dosing routes | SubQ | SubQ |
| Receptor targets | — | — |
| Half-life | — | — |
| Known side effects | 23 | 39 |
Research Areas
Top preclinical research areas — cited studies for each.
Teriparatide
- Causes the body to build new bone and increases bone strength and density
- Treats osteoporosis in postmenopausal women at high risk for fractures
- Increases bone mass in men with osteoporosis who are at high risk for fractures
- Treats corticosteroid-induced osteoporosis in men and women at high risk for fractures
- Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ)
Abaloparatide
- Builds new bone and increases bone strength and density
- Treats osteoporosis in postmenopausal women at high risk of fractures
- Treats osteoporosis in men at high risk of fracture
- Treatment of complex perianal fistulas in adult patients with Crohn’s disease
- Treatment of post-menopausal osteoporosis
How People Use It
Reported routines — research only, not medical advice.
Teriparatide
- SubQ — 20μg
Abaloparatide
- SubQ — 80 mcg
The Evidence
Key studies — click through to verify each on PubMed.
Teriparatide
1 sourced studies
- Source
Bone mineral density response rates are greater in patients treated with abaloparatide compared with those treated with placebo or teriparatide: Results from the ACTIVE phase 3 trial.
95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
Abaloparatide
12 sourced studies
- Source
Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials.
2023 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology → - Source
Abaloparatide
95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology → - Source
PubChem - Compound - Abaloparatide
95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology → - Source
"Tymlos- abaloparatide injection, solution"
95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
Decision Guide
How to Choose
Neither is a “winner” — they suit different goals. Compare the documented benefits and evidence above against what you’re actually trying to achieve, note the research status (approved vs research-stage), and read each full guide before deciding. Many people also stack peptides rather than pick one.
Source Teriparatide
Shop TeriparatideSource Abaloparatide